AMERIPRISE FINANCIAL INC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$608,000
-53.4%
40,705
-74.3%
0.00%
Q3 2022$1,306,000
+22.6%
158,692
-2.3%
0.00%
Q2 2022$1,065,000
+353.2%
162,400
+309.7%
0.00%
Q3 2020$235,00039,6400.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$22,809,0000.60%
SECTORAL ASSET MANAGEMENT INC 1,151,175$6,642,0000.47%
X-Square Capital, LLC 75,952$438,0000.24%
SABBY MANAGEMENT, LLC 68,092$393,0000.08%
WealthTrust Axiom LLC 22,347$128,0000.05%
Opaleye Management Inc. 58,800$339,0000.04%
Trexquant Investment LP 64,838$374,0000.04%
PDT Partners, LLC 60,117$347,0000.02%
PERSONAL CFO SOLUTIONS, LLC 13,000$75,0000.02%
CVI Holdings, LLC 13,171$76,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders